Torrent Pharmaceuticals Limited (TORNTPHARM.NS)
INR 3129.0
(0.07%)
INR 3129.0
(0.07%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 25.33 Billion INR | 19.63% |
| 2022 | 21.4 Billion INR | 20.95% |
| 2021 | 17.69 Billion INR | -2.93% |
| 2020 | 18.22 Billion INR | 20.01% |
| 2019 | 15.18 Billion INR | 10.97% |
| 2018 | 13.68 Billion INR | 45.5% |
| 2017 | 9.4 Billion INR | -13.21% |
| 2016 | 10.83 Billion INR | -56.81% |
| 2015 | 25.09 Billion INR | 202.6% |
| 2014 | 8.29 Billion INR | -12.92% |
| 2013 | 9.52 Billion INR | 52.06% |
| 2012 | 6.26 Billion INR | 39.9% |
| 2011 | 4.47 Billion INR | 26.22% |
| 2010 | 3.54 Billion INR | -2.47% |
| 2009 | 3.63 Billion INR | 65.36% |
| 2008 | 2.19 Billion INR | 30.35% |
| 2007 | 1.68 Billion INR | 34.74% |
| 2006 | 1.25 Billion INR | 50.66% |
| 2005 | 831.25 Million INR | 49.11% |
| 2004 | 557.46 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 7.07 Billion INR | 3.97% |
| 2024 Q2 | 7.41 Billion INR | 4.81% |
| 2023 Q4 | 6.8 Billion INR | 9.15% |
| 2023 FY | 25.6 Billion INR | 19.63% |
| 2023 Q2 | 6.5 Billion INR | 8.33% |
| 2023 Q3 | 6.23 Billion INR | -4.15% |
| 2023 Q1 | 6 Billion INR | 11.11% |
| 2022 Q4 | 5.4 Billion INR | 3.65% |
| 2022 Q2 | 5.32 Billion INR | -4.49% |
| 2022 FY | 21.4 Billion INR | 20.95% |
| 2022 Q1 | 5.57 Billion INR | 41.25% |
| 2022 Q3 | 5.21 Billion INR | -2.07% |
| 2021 FY | 17.69 Billion INR | -2.93% |
| 2021 Q4 | 3.94 Billion INR | 6.29% |
| 2021 Q2 | 4.92 Billion INR | -3.91% |
| 2021 Q3 | 3.71 Billion INR | -24.59% |
| 2021 Q1 | 5.12 Billion INR | 22.38% |
| 2020 Q1 | 5 Billion INR | 30.6% |
| 2020 FY | 18.22 Billion INR | 20.01% |
| 2020 Q2 | 4.7 Billion INR | -6.0% |
| 2020 Q3 | 4.4 Billion INR | -6.38% |
| 2020 Q4 | 4.18 Billion INR | -4.92% |
| 2019 Q1 | 3.81 Billion INR | 20.7% |
| 2019 Q2 | 3.78 Billion INR | -0.79% |
| 2019 Q3 | 3.77 Billion INR | -0.26% |
| 2019 Q4 | 3.82 Billion INR | 1.55% |
| 2019 FY | 15.18 Billion INR | 10.97% |
| 2018 Q1 | 3.27 Billion INR | 28.24% |
| 2018 Q3 | 4.05 Billion INR | 26.17% |
| 2018 FY | 13.68 Billion INR | 45.5% |
| 2018 Q2 | 3.21 Billion INR | -1.83% |
| 2018 Q4 | 3.15 Billion INR | -22.06% |
| 2017 Q2 | 2.45 Billion INR | 12.9% |
| 2017 Q4 | 2.55 Billion INR | -3.77% |
| 2017 Q3 | 2.65 Billion INR | 8.16% |
| 2017 FY | 9.4 Billion INR | -13.21% |
| 2017 Q1 | 2.17 Billion INR | 9.6% |
| 2016 Q1 | 3.95 Billion INR | -6.84% |
| 2016 FY | 10.83 Billion INR | -56.81% |
| 2016 Q4 | 1.98 Billion INR | -32.42% |
| 2016 Q3 | 2.93 Billion INR | -3.62% |
| 2016 Q2 | 3.04 Billion INR | -23.04% |
| 2015 Q4 | 4.24 Billion INR | -29.68% |
| 2015 FY | 25.09 Billion INR | 202.6% |
| 2015 Q1 | 9.17 Billion INR | 1197.15% |
| 2015 Q2 | 7.27 Billion INR | -20.72% |
| 2015 Q3 | 6.03 Billion INR | -17.06% |
| 2014 Q4 | -835.8 Million INR | -133.3% |
| 2014 FY | 8.29 Billion INR | -12.92% |
| 2014 Q2 | 2.89 Billion INR | -22.52% |
| 2014 Q1 | 3.73 Billion INR | -3.49% |
| 2014 Q3 | 2.51 Billion INR | -13.15% |
| 2013 Q4 | 3.86 Billion INR | 89.46% |
| 2013 Q1 | 1.95 Billion INR | 8.61% |
| 2013 FY | 9.52 Billion INR | 52.06% |
| 2013 Q2 | 1.67 Billion INR | -14.36% |
| 2013 Q3 | 2.04 Billion INR | 22.16% |
| 2012 Q1 | 1.5 Billion INR | 149.97% |
| 2012 Q2 | 1.46 Billion INR | -2.67% |
| 2012 Q3 | 1.49 Billion INR | 2.5% |
| 2012 Q4 | 1.79 Billion INR | 19.97% |
| 2012 FY | 6.26 Billion INR | 39.9% |
| 2011 FY | 4.47 Billion INR | 26.22% |
| 2011 Q3 | 1.14 Billion INR | 0.0% |
| 2011 Q4 | 600.07 Million INR | -47.5% |
| 2010 FY | 3.54 Billion INR | -2.47% |
| 2009 FY | 3.63 Billion INR | 65.36% |
| 2008 FY | 2.19 Billion INR | 30.35% |
| 2007 FY | 1.68 Billion INR | 34.74% |
| 2006 FY | 1.25 Billion INR | 50.66% |
| 2005 FY | 831.25 Million INR | 49.11% |
| 2004 FY | 557.46 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | -339.992% |
| Hester Biosciences Limited | 364.77 Million INR | -6845.527% |
| Aarti Drugs Limited | 7.14 Billion INR | -254.402% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | -709.919% |
| Albert David Limited | 1.33 Billion INR | -1798.54% |
| Alembic Limited | 767.77 Million INR | -3199.842% |
| Alkem Laboratories Limited | 19.46 Billion INR | -30.178% |
| Bafna Pharmaceuticals Limited | 237.66 Million INR | -10560.226% |
| Bajaj HealthCare Limited | - INR | -Infinity% |
| Biofil Chemicals and Pharmaceuticals Limited | 20.65 Million INR | -122552.982% |
| Brooks Laboratories Limited | -72.25 Million INR | 35165.05% |
| Eris Lifesciences Limited | 5.18 Billion INR | -388.934% |
| FDC Limited | 3.03 Billion INR | -735.114% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | -182.155% |
| Gufic Biosciences Limited | 2.89 Billion INR | -775.498% |
| Hikal Limited | 1.49 Billion INR | -1595.57% |
| Ind-Swift Limited | 1.22 Billion INR | -1966.553% |
| Innova Captab Limited | 2.53 Billion INR | -900.043% |
| IOL Chemicals and Pharmaceuticals Limited | 4.94 Billion INR | -412.63% |
| Jagsonpal Pharmaceuticals Limited | 214.04 Million INR | -11736.666% |
| Jubilant Pharmova Limited | 5.18 Billion INR | -388.248% |
| Lincoln Pharmaceuticals Limited | 1.9 Billion INR | -1229.005% |
| Lupin Limited | 27.75 Billion INR | 8.729% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | -92168.92% |
| Medico Remedies Limited | 277.11 Million INR | -9042.387% |
| Morepen Laboratories Limited | 4.17 Billion INR | -507.001% |
| Nectar Lifesciences Limited | 3.89 Billion INR | -551.192% |
| Orchid Pharma Limited | 2.36 Billion INR | -973.035% |
| Procter & Gamble Health Limited | 2.78 Billion INR | -809.375% |
| RPG Life Sciences Limited | 2.29 Billion INR | -1005.231% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | -12077.457% |
| Sigachi Industries Limited | 1.47 Billion INR | -1618.927% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | 757.562% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | -449.852% |
| Themis Medicare Limited | 1.3 Billion INR | -1844.218% |
| Unichem Laboratories Limited | - INR | -Infinity% |
| Vaishali Pharma Limited | 6.29 Million INR | -402429.393% |
| Wanbury Limited | 1.7 Billion INR | -1384.015% |
| Windlas Biotech Limited | 1.29 Billion INR | -1850.527% |
| ZIM Laboratories Limited | 1.09 Billion INR | -2207.158% |
| Ind-Swift Laboratories Limited | 2 Billion INR | -1161.064% |
| Ipca Laboratories Limited | 29.59 Billion INR | 14.398% |
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 75.71% |
| Venus Remedies Limited | 534.65 Million INR | -4638.643% |
| Sakar Healthcare Limited | 495.5 Million INR | -5012.996% |
| Aurobindo Pharma Limited | 104.5 Billion INR | 75.757% |
| Divi's Laboratories Limited | 18.31 Billion INR | -38.368% |
| AstraZeneca Pharma India Limited | 4.47 Billion INR | -466.289% |
| Mankind Pharma Limited | 40.86 Billion INR | 38.007% |
| Sequent Scientific Limited | - INR | -Infinity% |
| Laurus Labs Limited | 3.94 Billion INR | -541.625% |
| Neuland Laboratories Limited | 5.31 Billion INR | -376.396% |
| J. B. Chemicals & Pharmaceuticals Limited | 7.54 Billion INR | -235.937% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | -289.63% |
| Zydus Lifesciences Limited | 45.39 Billion INR | 44.186% |
| Amrutanjan Health Care Limited | 621.02 Million INR | -3979.565% |
| Wockhardt Limited | 140 Million INR | -17996.571% |
| Bal Pharma Limited | 214.56 Million INR | -11707.484% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 62.593% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | -1958.097% |
| Par Drugs and Chemicals Limited | 551.58 Million INR | -4493.13% |
| Caplin Point Laboratories Limited | 7.22 Billion INR | -250.646% |
| Shilpa Medicare Limited | 3.76 Billion INR | -573.527% |
| Valiant Laboratories Limited | - INR | -Infinity% |
| Ajanta Pharma Limited | 19.67 Billion INR | -28.753% |
| Aarey Drugs & Pharmaceuticals Limited | 2.83 Million INR | -894875.53% |
| Granules India Limited | 6.52 Billion INR | -288.085% |
| Medicamen Biotech Limited | - INR | -Infinity% |
| Syncom Formulations (India) Limited | 249.25 Million INR | -10064.533% |
| Piramal Enterprises Limited | - INR | -Infinity% |
| NATCO Pharma Limited | 25.96 Billion INR | 2.414% |
| Suven Life Sciences Limited | -1.22 Billion INR | 2166.793% |
| Krebs Biochemicals & Industries Limited | - INR | -Infinity% |
| Strides Pharma Science Limited | 5.22 Billion INR | -384.809% |
| Indoco Remedies Limited | 1.52 Billion INR | -1561.978% |
| Alpa Laboratories Limited | 61.51 Million INR | -41085.402% |
| Lasa Supergenerics Limited | -458 Million INR | 5631.643% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 715.673% |